• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减毒活流感 A 病毒疫苗可预防 A(H1N1)pdm09 异源挑战,而不会引起与疫苗相关的加重呼吸道疾病。

Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.

机构信息

Virus and Prion Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA 50010, USA; Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA.

Virus and Prion Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA 50010, USA.

出版信息

Virology. 2014 Dec;471-473:93-104. doi: 10.1016/j.virol.2014.10.003. Epub 2014 Oct 28.

DOI:10.1016/j.virol.2014.10.003
PMID:25461535
Abstract

Live-attenuated influenza virus (LAIV) vaccines may provide cross-protection against contemporary influenza A virus (IAV) in swine. Conversely, whole inactivated virus (WIV) vaccines have the potential risk of vaccine-associated enhanced respiratory disease (VAERD) when challenged with IAV of substantial antigenic drift. A temperature sensitive, intranasal H1N2 LAIV was compared to wild type exposure (WT) and an intramuscular WIV vaccine in a model shown to induce VAERD. WIV vaccinated swine challenged with pandemic A/H1N1 (H1N1pdm09) were not protected from infection and demonstrated severe respiratory disease consistent with VAERD. Lung lesions were mild and challenge virus was not detected in the respiratory tract of LAIV vaccinates. High levels of post-vaccination IgG serum antibodies targeting the H1N1pdm09 HA2 stalk domain were exclusively detected in the WIV group and associated with increased H1N1pdm09 virus infectivity in MDCK cells. In contrast, infection-enhancing antibodies were not detected in the serum of LAIV vaccinates and VAERD was not observed.

摘要

减毒活流感病毒 (LAIV) 疫苗可能为猪提供针对当代甲型流感病毒 (IAV) 的交叉保护。相反,全灭活病毒 (WIV) 疫苗在受到具有大量抗原漂移的 IAV 挑战时,有疫苗相关增强呼吸道疾病 (VAERD) 的潜在风险。在已证明可诱导 VAERD 的模型中,比较了一种温度敏感的鼻内 H1N2 LAIV 与野生型暴露 (WT) 和肌肉内 WIV 疫苗。用大流行性 A/H1N1 (H1N1pdm09) 对接受 WIV 疫苗接种的猪进行攻毒,并未免受感染,表现出与 VAERD 一致的严重呼吸道疾病。肺损伤轻微,呼吸道中未检测到 LAIV 疫苗接种的呼吸道病毒。高水平的针对 H1N1pdm09 HA2 茎域的 H1N1pdm09 血凝素的接种后 IgG 血清抗体仅在 WIV 组中检测到,并且与 MDCK 细胞中 H1N1pdm09 病毒感染力增加有关。相比之下,在 LAIV 疫苗接种者的血清中未检测到感染增强抗体,也未观察到 VAERD。

相似文献

1
Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.减毒活流感 A 病毒疫苗可预防 A(H1N1)pdm09 异源挑战,而不会引起与疫苗相关的加重呼吸道疾病。
Virology. 2014 Dec;471-473:93-104. doi: 10.1016/j.virol.2014.10.003. Epub 2014 Oct 28.
2
Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs.甲型流感病毒血凝素蛋白亚单位疫苗在猪身上引发与疫苗相关的呼吸道疾病加重。
Vaccine. 2014 Sep 8;32(40):5170-6. doi: 10.1016/j.vaccine.2014.07.059. Epub 2014 Jul 29.
3
Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.接种疫苗时的年龄和感染时间不会改变甲型流感病毒感染猪的疫苗相关增强型呼吸道疾病。
Clin Vaccine Immunol. 2016 Jun 6;23(6):470-482. doi: 10.1128/CVI.00563-15. Print 2016 Jun.
4
Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.用大流行(2009)A/H1N1流感病毒攻毒诱导的疫苗相关性增强型呼吸道疾病猪的肺部病变发展动力学及促炎细胞因子反应
Vet Pathol. 2012 Nov;49(6):900-12. doi: 10.1177/0300985812439724. Epub 2012 Mar 28.
5
Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009.疫苗相关增强性呼吸道疾病并不会干扰大流行性 A/H1N1 2009 感染后的适应性免疫应答。
Viral Immunol. 2013 Oct;26(5):314-21. doi: 10.1089/vim.2013.0018. Epub 2013 Sep 13.
6
Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.接种灭活的人源样(δ 谱系)H1N2 疫苗并感染 2009 年大流行 H1N1 流感病毒的猪增强型肺炎和疾病。
Vaccine. 2011 Mar 24;29(15):2712-9. doi: 10.1016/j.vaccine.2011.01.082. Epub 2011 Feb 23.
7
Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines.全灭活流感病毒疫苗中的血凝素和神经氨酸酶会影响疫苗相关的呼吸道疾病加重情况。
J Gen Virol. 2016 Jul;97(7):1489-1499. doi: 10.1099/jgv.0.000468. Epub 2016 Mar 31.
8
Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.疫苗诱导的抗 HA2 抗体促进病毒融合并增强流感病毒呼吸道疾病。
Sci Transl Med. 2013 Aug 28;5(200):200ra114. doi: 10.1126/scitranslmed.3006366.
9
Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets.在母源抗体存在的情况下进行异源攻毒会导致断奶仔猪出现疫苗相关的呼吸道疾病加重。
Virology. 2016 Apr;491:79-88. doi: 10.1016/j.virol.2016.01.015. Epub 2016 Feb 11.
10
Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.口腔液体作为猪经鼻接种甲型流感病毒疫苗后评估交叉反应性和交叉保护性的活体动物样本来源
Clin Vaccine Immunol. 2015 Oct;22(10):1109-20. doi: 10.1128/CVI.00358-15. Epub 2015 Aug 19.

引用本文的文献

1
Epitope-optimized vaccine elicits enduring immunity against swine influenza A virus.表位优化疫苗引发针对甲型猪流感病毒的持久免疫力。
Nat Commun. 2025 Apr 30;16(1):4046. doi: 10.1038/s41467-025-59182-7.
2
Eurasian 1C swine influenza A virus exhibits high pandemic risk traits.欧亚1C型甲型流感病毒具有高流行风险特征。
Emerg Microbes Infect. 2025 Dec;14(1):2492210. doi: 10.1080/22221751.2025.2492210. Epub 2025 May 7.
3
One health: Subchronic exposure to low ambient hydrogen sulfide increases mortality of influenza A virus infection in mice.
同一健康:亚慢性暴露于低环境硫化氢会增加小鼠甲型流感病毒感染的死亡率。
Environ Res. 2025 Feb 1;266:120536. doi: 10.1016/j.envres.2024.120536. Epub 2024 Dec 6.
4
Lipid nanoparticle-encapsulated DNA vaccine confers protection against swine and human-origin H1N1 influenza viruses.脂质纳米颗粒包裹的 DNA 疫苗可预防猪源和人源 H1N1 流感病毒。
mSphere. 2024 Aug 28;9(8):e0028324. doi: 10.1128/msphere.00283-24. Epub 2024 Aug 1.
5
Spontaneous Lethal Outbreak of Influenza A Virus Infection in Vaccinated Sows on Two Farms Suggesting the Occurrence of Vaccine-Associated Enhanced Respiratory Disease with Eosinophilic Lung Pathology.两农场接种疫苗母猪发生的流感 A 病毒感染自发致死性暴发提示存在疫苗相关增强呼吸道疾病伴嗜酸性肺炎病变。
Viruses. 2024 Jun 13;16(6):955. doi: 10.3390/v16060955.
6
Assessment of Immune Responses to a Trivalent Pichinde Virus-Vectored Vaccine Expressing Hemagglutinin Genes from Three Co-Circulating Influenza A Virus Subtypes in Pigs.评估猪对一种表达来自三种共同流行甲型流感病毒亚型血凝素基因的三价皮钦德病毒载体疫苗的免疫反应。
Vaccines (Basel). 2023 Dec 2;11(12):1806. doi: 10.3390/vaccines11121806.
7
Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model.在猪模型中,异源初免-加强 H1N1 疫苗接种会加剧与不匹配的 H1N2 流感病毒攻击后的疾病。
Front Immunol. 2023 Oct 20;14:1253626. doi: 10.3389/fimmu.2023.1253626. eCollection 2023.
8
A Single-Dose Intramuscular Immunization of Pigs with Lipid Nanoparticle DNA Vaccines Based on the Hemagglutinin Antigen Confers Complete Protection against Challenge Infection with the Homologous Influenza Virus Strain.基于血凝素抗原的脂质纳米颗粒DNA疫苗对猪进行单剂量肌肉注射免疫可使其获得针对同源流感病毒株攻毒感染的完全保护。
Vaccines (Basel). 2023 Oct 15;11(10):1596. doi: 10.3390/vaccines11101596.
9
Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs.表达流感病毒血凝素抗原的重组皮钦德病毒载体疫苗在猪体内的免疫原性和保护效力
Vaccines (Basel). 2022 Aug 26;10(9):1400. doi: 10.3390/vaccines10091400.
10
Vaccine-Associated Enhanced Respiratory Disease following Influenza Virus Infection in Ferrets Recapitulates the Model in Pigs.感染流感病毒后雪貂疫苗相关增强性呼吸道疾病模型重现于猪。
J Virol. 2022 Mar 9;96(5):e0172521. doi: 10.1128/JVI.01725-21. Epub 2022 Jan 5.